CD8A and neoplasm: Metformin was also shown to increase the effect of anti-PD1-therapy in melanoma cells, by alleviating CD8+ T cell suppression through inhibition of cancer cell oxygen consumption and consequent reduction of the hypoxic tumor microenvironment [191].